Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab
Giulia Martini, Davide Ciardiello, Marcello Dallio, et al.
International Journal of Cancer (2022) Vol. 151, Iss. 3, pp. 473-480
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Gut microbiota in colorectal cancer development and therapy
Chi Chun Wong, Jun Yu
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 7, pp. 429-452
Closed Access | Times Cited: 278
Predictive biomarkers of colon cancer immunotherapy: Present and future
Wanting Hou, Yi Cheng, Hong Zhu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 89
Immune-based combination therapy to convert immunologically cold tumors into hot tumors: an update and new insights
Jiaojiao Ni, Zizhen Zhang, Ming-jie Ge, et al.
Acta Pharmacologica Sinica (2022) Vol. 44, Iss. 2, pp. 288-307
Open Access | Times Cited: 39
Echinacoside inhibits colorectal cancer metastasis via modulating the gut microbiota and suppressing the PI3K/AKT signaling pathway
Jiao Wei, Zongmei Zheng, Xinxin Hou, et al.
Journal of Ethnopharmacology (2023) Vol. 318, pp. 116866-116866
Closed Access | Times Cited: 28
Combined analysis of gut microbiome and serum metabolomics reveals novel biomarkers in patients with early-stage non-small cell lung cancer
Boxiong Ni, Xianglong Kong, Yubo Yan, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 23
Digestion under saliva, simulated gastric and small intestinal conditions and fermentation in vitro by human gut microbiota of polysaccharides from Ficus carica Linn.
Bing Xu, Shiqing Song, Lingyun Yao, et al.
Food Hydrocolloids (2023) Vol. 146, pp. 109204-109204
Closed Access | Times Cited: 23
Targeting the EGFR signalling pathway in metastatic colorectal cancer
Stefania Napolitano, Giulia Martini, Davide Ciardiello, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 7, pp. 664-676
Closed Access | Times Cited: 13
The role of the gut microbiota in tumor, immunity, and immunotherapy
Yuyan Xie, Fang Liu
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Role of the gut microbiota in tumorigenesis and treatment
Qingya Liu, Yun Yang, Meng Pan, et al.
Theranostics (2024) Vol. 14, Iss. 6, pp. 2304-2328
Open Access | Times Cited: 11
Gut microbiota and dietary intervention: affecting immunotherapy efficacy in non–small cell lung cancer
Yu Xin, Chenguang Liu, Dan Zang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
The role of anti-EGFR rechallenge in metastatic colorectal cancer, from available data to future developments: A systematic review
Davide Ciardiello, Gianluca Mauri, Andrea Sartore‐Bianchi, et al.
Cancer Treatment Reviews (2024) Vol. 124, pp. 102683-102683
Closed Access | Times Cited: 8
Identification and Application of Emerging Biomarkers in Treatment of Non-Small-Cell Lung Cancer: Systematic Review
Juan Carlos Restrepo, Darly Martínez Guevara, Andrés Pareja López, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2338-2338
Open Access | Times Cited: 8
Exploring the Role of the Gut Microbiota in Modulating Colorectal Cancer Immunity
Nikolay K. Shakhpazyan, Л.М. Михалева, A.L. Bedzhanyan, et al.
Cells (2024) Vol. 13, Iss. 17, pp. 1437-1437
Open Access | Times Cited: 8
Gut Microbiota–Tumor Microenvironment Interactions: Mechanisms and Clinical Implications for Immune Checkpoint Inhibitor Efficacy in Cancer
Sawsan Sudqi Said, Wisam Nabeel Ibrahim
Cancer Management and Research (2025) Vol. Volume 17, pp. 171-192
Open Access | Times Cited: 1
The impact of microbiota on PD-1/PD-L1 inhibitor therapy outcomes: A focus on solid tumors
Sajad Najafi, Jamal Majidpoor, Keywan Mortezaee
Life Sciences (2022) Vol. 310, pp. 121138-121138
Closed Access | Times Cited: 24
Gut microbiota composition in patients with advanced malignancies experiencing immune-related adverse events
Xinyu Liu, Hao Tang, Qingyang Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Gut microbiota signatures in tissues of the colorectal polyp and normal colorectal mucosa, and faeces
Xiaohui Zhong, Yuanyuan Wang, Jianmin Xu, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 12
Open Access | Times Cited: 14
The Gut Microbiome from a Biomarker to a Novel Therapeutic Strategy for Immunotherapy Response in Patients with Lung Cancer
Sreya Duttagupta, Taiki Hakozaki, Bertrand Routy, et al.
Current Oncology (2023) Vol. 30, Iss. 11, pp. 9406-9427
Open Access | Times Cited: 13
Oral probiotics microgel plus Galunisertib reduced TGF-β blockade resistance and enhanced anti-tumor immune responses in colorectal cancer
Lili Niu, Yao Liu, Nannan Li, et al.
International Journal of Pharmaceutics (2024) Vol. 652, pp. 123810-123810
Closed Access | Times Cited: 5
Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomes
Jiexi Yan, Lu Yang, Qingmiao Ren, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
Hidden Partner of Immunity: Microbiome as an Innovative Companion in Immunotherapy
P. Kim, Sook-Haeng Joe, Heeyoung Kim, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 856-856
Open Access
Microbial dysbiosis with tryptophan metabolites alteration in lower respiratory tract is associated with clinical responses to anti-PD-1 immunotherapy in advanced non-small cell lung cancer
Xiang-xiang Chen, Qing Ju, Dan Qiu, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 4
Open Access
Gut microbiota as a new target for anticancer therapy: from mechanism to means of regulation
Jiaao Sun, Shiyan Song, Jiahua Liu, et al.
npj Biofilms and Microbiomes (2025) Vol. 11, Iss. 1
Open Access
Operationalizing Team Science at the Academic Cancer Center Network to Unveil the Structure and Function of the Gut Microbiome
Kevin McDonnell
Journal of Clinical Medicine (2025) Vol. 14, Iss. 6, pp. 2040-2040
Open Access
Page 1 - Next Page

Scroll to top